Russia’s first clinical trial of another vaccine was successful, approval can be found soon

The number of people infected with the corona virus in the world is increasing day by day. So far, 34 million people worldwide have been infected with the Corona virus. At the same time, 10.27 lakh people have died due to this epidemic.

At the same time, teams of scientists in many countries are constantly working on this to prevent the corona virus. At the same time, Russia had launched the first corona vaccine, claiming successful treatment on corona virus infection. At the same time, taking another step towards the Corona vaccine, another Russian vaccine has passed its first clinical test.

Russia’s Vecator in Siberia, a top-secret State Virology Research Center, has said that Russia’s second Corona vaccine has been successful in initial phase testing. Its name is being told as Epivacorona. The Wackter’s press department told the Interfax news agency that the first two phases of the clinical trial demonstrated the effectiveness and safety of the Epivacorona vaccine.

Russia’s Health Minister Mikhail Murashko told President Vladimir Putin this week that Vaccator’s vaccine could be approved by the ministry in three weeks. On this, it was said by the vectors that after registration, clinical trials will start in 5,000 Volunteers in Siberia. The lab said there will be a separate clinical trial involving 150 volunteers who are over 60 years of age.